Market Overview

Benzinga's Top #PreMarket Losers

Related GERN
Oppenheimer Is Excited About These 3 Biotech Stocks
Benzinga's Top #PreMarket Gainers
Trio Of Small Biotechs With Upcoming 2015 Catalysts And Enormous Long-Term Potential (Seeking Alpha)
Related FRME
6 Images Every Regional Bank Investor Should See
LNB Bancorp Upped to Strong Buy - Analyst Blog

Geron (NASDAQ: GERN) shares fell 21.53% to $4.41 in the pre-market trading. Geron's PEG ratio is -3.94.

First Merchants (NASDAQ: FRME) dipped 7.01% to $19.50 in the pre-market session. First Merchants is expected to report its Q4 financial results on January 28, 2014.

GW Pharmaceuticals plc (NASDAQ: GWPH) dipped 4.11% to $47.13. GW Pharmaceuticals' trailing-twelve-month profit margin is -14.81%.

Vodafone Group Public Limited Company (NASDAQ: VOD) shares dropped 3.50% to $36.71 in pre-market trading. AT&T (NYSE: T) confirmed that it does not intend to make an offer for Vodafone.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (FRME + GERN)

Around the Web, We're Loving...